Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.

BMC Neurol · 2020 · PMC7607674 · PMID 33143640

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

More than twice as many saline group patients (28%, 7/25) had vasospasm than those in the Cerebrolysin group (12%, 3/25), but this also did not reach statistical significance (OR 0.35; 95% CI 0.08–1.55).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.